Key Takeaways From ASCRS 2025: Understanding Recent Data for Treating Dry Eye Disease

home / post-conference-perspectives / key-takeaways-from-ascrs-2025-understanding-recent-data-for-treating-dry-eye-disease

A panelist discusses how recent clinical studies on dry eye disease emphasize the importance of precise diagnosis and targeted treatments such as cyclosporine formulations and varenicline nasal spray in improving tear film stability, reducing inflammation, and enhancing patient outcomes, while highlighting challenges such as delayed symptom relief, medication adherence, and the need for ongoing research into meibomian gland dysfunction.

Episodes

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo